药品注册申请号:088481
申请类型:ANDA (仿制药申请)
申请人:ALVOGEN
申请人全名:ALVOGEN INC
产品信息
产品号商品名活性成分剂型/给药途径规格/剂量参比药物(RLD)生物等效参考标准(RS)治疗等效代码该申请号批准日期该产品号批准日期市场状态
001 DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 6MG No No AB 1983/12/15 1983/11/28 Prescription
002 DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 0.5MG No No BP 1983/04/28 Prescription
003 DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 0.75MG No No BP 1983/04/28 Prescription
004 DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG No No AB 1983/04/28 Prescription
批准日期,申请提交历史,通知信,药品说明书,审评文件等信息
提交状态日期提交号审批结论申请内容分类审评优先级;罕用药状态通知信、审评文件、说明书、包装标签备注
2024/06/05 SUPPL-32(补充) Approval Labeling STANDARD
2022/01/14 SUPPL-27(补充) Approval Manufacturing (CMC) UNKNOWN
2008/07/24 SUPPL-22(补充) Approval Labeling
2002/12/06 SUPPL-20(补充) Approval Manufacturing (CMC)
1997/11/26 SUPPL-19(补充) Approval Manufacturing (CMC)
1997/11/26 SUPPL-18(补充) Approval Manufacturing (CMC)
1997/08/12 SUPPL-17(补充) Approval Manufacturing (CMC)
1995/10/30 SUPPL-16(补充) Approval Labeling
1994/04/28 SUPPL-15(补充) Approval Labeling
1992/04/29 SUPPL-14(补充) Approval Labeling
1990/09/18 SUPPL-13(补充) Approval Labeling
1990/01/23 SUPPL-12(补充) Approval Labeling
1989/07/31 SUPPL-11(补充) Approval Labeling
1988/09/16 SUPPL-10(补充) Approval Manufacturing (CMC)
1986/05/01 SUPPL-8(补充) Approval Manufacturing (CMC)
1986/05/01 SUPPL-6(补充) Approval Manufacturing (CMC)
1984/03/26 SUPPL-2(补充) Approval Manufacturing (CMC)
1984/03/26 SUPPL-1(补充) Approval Manufacturing (CMC)
1983/12/15 ORIG-1(原始申请) Approval
与本品相关的专利信息(来自FDA橙皮书Orange Book)
关联产品号专利号专利过期日是否物质专利是否产品专利专利用途代码撤销请求提交日期专利下载备注
与本品相关的市场独占权保护信息
关联产品号独占权代码失效日期备注
与本品治疗等效的药品
活性成分:DEXAMETHASONE 剂型/给药途径:TABLET;ORAL 规格:6MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
088316 001 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 6MG Prescription Yes Yes AB 1983/09/15 HIKMA
088481 001 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 6MG Prescription No No AB 1983/11/28 ALVOGEN
215106 002 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 6MG Prescription No No AB 2021/10/14 AMNEAL
215604 003 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 6MG Prescription No No AB 2022/08/08 NOVITIUM PHARMA
217001 002 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 6MG Prescription No No AB 2023/04/19 BIONPHARMA
217695 007 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 6MG Prescription No No AB 2023/08/23 APOTEX
216282 005 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 6MG Prescription No No AB 2024/02/07 ZYDUS LIFESCIENCES
218372 007 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 6MG Prescription No No AB 2024/09/17 COREPHARMA
活性成分:DEXAMETHASONE 剂型/给药途径:TABLET;ORAL 规格:0.5MG 治疗等效代码:BP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
088481 002 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 0.5MG Prescription No No BP 1983/04/28 ALVOGEN
活性成分:DEXAMETHASONE 剂型/给药途径:TABLET;ORAL 规格:0.75MG 治疗等效代码:BP
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
088481 003 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 0.75MG Prescription No No BP 1983/04/28 ALVOGEN
活性成分:DEXAMETHASONE 剂型/给药途径:TABLET;ORAL 规格:4MG 治疗等效代码:AB
申请号产品号申请类型商品名活性成分剂型/给药途径规格市场状态RLDRSTE Code产品号批准日期申请人
084612 001 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG Prescription Yes No AB Approved Prior to Jan 1, 1982 HIKMA
088481 004 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG Prescription No No AB 1983/04/28 ALVOGEN
215106 001 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG Prescription No No AB 2021/10/14 AMNEAL
080399 002 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG Prescription No No AB 2022/04/20 PRASCO
215604 002 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG Prescription No No AB 2022/08/08 NOVITIUM PHARMA
217001 001 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG Prescription No No AB 2023/04/19 BIONPHARMA
217695 006 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG Prescription No No AB 2023/08/23 APOTEX
216282 004 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG Prescription No No AB 2024/02/07 ZYDUS LIFESCIENCES
218372 006 ANDA DEXAMETHASONE DEXAMETHASONE TABLET;ORAL 4MG Prescription No No AB 2024/09/17 COREPHARMA
更多信息
药品NDC数据与药品包装、标签说明书
©2006-2024 DrugFuture->U.S. FDA Drugs Database